Search
GT Biopharma Inc
GTBPAdd to Watchlist
7.180USD
+0.020+0.28%
Close 09-21 16:00（ET）
12.51MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.28%
5 Days
-38.26%
1 Month
-0.62%
6 Months
-37.57%
Year to Date
-63.41%
1 Year
-63.27%
Key Figures
7.160Open
7.820High
2.66KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.15%Turnover Ratio
7.160Prev. Close
6.880Low
19.34KTurnover
LossP/E Static
3.50P/B
0.00%Div Yield TTM
-480.65%ROA
11.98052wk High
4.65Volume Ratio
-13.16MNet Profit
1.79MShares
-6.0287EPS TTM
0.79Beta
-1122.83%ROE
5.55052wk Low
10.75%Amplitude
--Gross Margin
12.51MMarket Cap
-1.90Reward/Risk
131.47%Risk Rate
More news coming soon, stay tuned...
GT Biopharma Inc's Score
-0.25vs previous score
Forecast8.00
Financial Health7.52
Technical7.31
Valuation Dimensions7.80
Institutional Confidence3.00
Risk Assessment1.80
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
GT Biopharma Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-2.96/-0.08
Revenue / Forecast
0.00/0.00
GT Biopharma Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolGTBP
Number of employees1
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Bristol Capital Advisors, LLC | 2.80% |
| Marzilli (Robert A) | 2.22% |
| Vanguard Capital Management, LLC | 1.43% |
| Breen (Michael Martin) | 0.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 3.48% |
| Individual Investor | 3.38% |
| Hedge Fund | 3.10% |
| Corporation | 0.52% |
Related Instruments
+1.04%
-0.19%
+1.22%
+0.20%
+1.79%
+0.43%
+1.95%
+0.30%
+0.29%
-7.96%
+0.47%
-0.70%
+1.71%
+1.35%
+0.05%
+1.70%
+12.27%
-0.21%
-0.11%
+0.16%
FAQs
What is the current price of GT Biopharma Inc (GTBP)?
The current price of GT Biopharma Inc (GTBP) is 7.18.
What is the symbol of GT Biopharma Inc?
The ticker symbol of GT Biopharma Inc is GTBP.
What is the 52-week high of GT Biopharma Inc?
The 52-week high of GT Biopharma Inc is 11.98.
What is the 52-week low of GT Biopharma Inc?
The 52-week low of GT Biopharma Inc is 5.55.
What is the market capitalization of GT Biopharma Inc?
The market capitalization of GT Biopharma Inc is 12.51M.
Is GT Biopharma Inc (GTBP) currently rated as Buy, Hold, or Sell?
According to analysts, GT Biopharma Inc (GTBP) has an overall rating of Buy, with a price target of 75.00.
What is the Earnings Per Share (EPS TTM) of GT Biopharma Inc (GTBP)?
The Earnings Per Share (EPS TTM) of GT Biopharma Inc (GTBP) is -6.03.